Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
1.
Mucosal Immunol ; 9(1): 13-23, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25943275

RESUMEN

There have been encouraging results for the development of an effective HIV vaccine. However, many questions remain regarding the quality of immune responses and the role of mucosal antibodies. We addressed some of these issues by using a simian immunodeficiency virus (SIV) DNA vaccine adjuvanted with plasmid-expressed mucosal chemokines combined with an intravaginal SIV challenge in rhesus macaque (RhM) model. We previously reported on the ability of CCR9 and CCR10 ligand (L) adjuvants to enhance mucosal and systemic IgA and IgG responses in small animals. In this study, RhMs were intramuscularly immunized five times with either DNA or DNA plus chemokine adjuvant delivered by electroporation followed by challenge with SIVsmE660. Sixty-eight percent of all vaccinated animals (P<0.01) remained either uninfected or had aborted infection compared with only 14% in the vaccine naïve group. The highest protection was observed in the CCR10L chemokines group, where six of nine animals had aborted infection and two remained uninfected, leading to 89% protection (P<0.001). The induction of mucosal SIV-specific antibodies and neutralization titers correlated with trends in protection. These results indicate the need to further investigate the contribution of chemokine adjuvants to modulate immune responses and the role of mucosal antibodies in SIV/HIV protection.


Asunto(s)
Vacunas contra el SIDA/administración & dosificación , Anticuerpos Antivirales/biosíntesis , Quimiocinas/inmunología , Inmunidad Mucosa/efectos de los fármacos , Síndrome de Inmunodeficiencia Adquirida del Simio/prevención & control , Vacunas de ADN/administración & dosificación , Vacunas contra el SIDA/genética , Vacunas contra el SIDA/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Animales , Quimiocinas/administración & dosificación , Quimiocinas/genética , Femenino , Inmunidad Celular/efectos de los fármacos , Ligandos , Macaca mulatta , Plásmidos/química , Plásmidos/inmunología , Receptores CCR/genética , Receptores CCR/inmunología , Receptores CCR10/genética , Receptores CCR10/inmunología , Síndrome de Inmunodeficiencia Adquirida del Simio/inmunología , Síndrome de Inmunodeficiencia Adquirida del Simio/virología , Virus de la Inmunodeficiencia de los Simios/efectos de los fármacos , Virus de la Inmunodeficiencia de los Simios/inmunología , Vacunación , Vacunas de ADN/genética , Vacunas de ADN/inmunología , Vagina/efectos de los fármacos , Vagina/inmunología , Vagina/virología
2.
Int J Tuberc Lung Dis ; 19(8): 927-35, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26162359

RESUMEN

SETTING: Public human immunodeficiency virus (HIV) clinic and tuberculosis (TB) clinics in Kampala, Uganda. OBJECTIVE: To examine TB-specific CD4 T-cell single and polyfunctional cytokine correlates of clinical diagnostic tests for latent tuberculous infection (LTBI) in HIV-1-infected subjects. DESIGN: Thirty antiretroviral therapy-naïve HIV-1-infected adults without active TB disease underwent clinical tuberculin skin test (TST), interferon-gamma release assay (IGRA), and in vitro flow cytometry analysis on cells stimulated with purified protein derivative (PPD) and TB antigens early secreted antigenic target 6 + culture filtrate protein 10 (EC) for frequencies of interleukin (IL) 2, IL-17, interferon-gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) expressing cells. RESULTS: PPD-specific CD4 T-cell expression of TNF-α and IFN-γ was higher in the TST-positive than in the TST-negative group. EC-specific CD4 T-cell expression of TNF-α and IL-2 was higher in the TST+ group than in the TST- group. Expression of both PPD and EC-specific expression of IL-2, IFN-γ and TNF-α were greater in IGRA-positive than in IGRA-negative subjects. The TST+ group exhibited greater polyfunctionality than the TST- group. All cytokine combinations that contained TNF-α correlated strongly with TST size. CONCLUSION: While IL-2, IFN-γ and TNF-α correlate with clinical tests of LTBI, TNF-α is the dominant cytokine correlating with both TST size and magnitude of IGRA response.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Citocinas/inmunología , Infecciones por VIH/complicaciones , Tuberculosis Latente/diagnóstico , Adulto , Femenino , Citometría de Flujo/métodos , VIH-1/aislamiento & purificación , Humanos , Ensayos de Liberación de Interferón gamma/métodos , Tuberculosis Latente/inmunología , Masculino , Tuberculina/inmunología , Prueba de Tuberculina/métodos , Uganda
3.
Tuberculosis (Edinb) ; 91(3): 224-30, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21459675

RESUMEN

Pleural tuberculosis (TB) is a common presentation of Mycobacterium tuberculosis (MTB) infection, and despite spontaneous resolution remains a strong risk factor for reactivation pulmonary TB in a majority of individuals. This study was undertaken to further understand the characteristics of immune cells at sites of pleural TB. A significant shift toward memory CD4+ T cells with an effector phenotype and away from naïve CD4+ T cells in pleural fluid as compared to blood mononuclear cells was found. These data suggest that effector T cells are capable of migrating to sites of active TB infection and/or the differentiation to effector phenotype T cells in situ is highly amplified. Using multi-parameter flow cytometry analysis, a significant portion of MTB-specific CD4+ T cells in the pleural space were polyfunctional demonstrating two, three or four simultaneous functions including IFN-gamma, IL-2, TNF-alpha, and or MIP-1 alpha production. A greater proportion of these polyfunctional cells were of effector memory rather than central memory phenotype. The role of these polyfunctional MTB-specific CD4+ T cells at sites of pleural TB requires further study.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Mycobacterium tuberculosis/inmunología , Tuberculosis Pleural/inmunología , Adolescente , Adulto , Anciano , Linfocitos T CD4-Positivos/metabolismo , Quimiocina CCL3/biosíntesis , Femenino , Citometría de Flujo , Humanos , Interferón gamma/biosíntesis , Interleucina-2/biosíntesis , Masculino , Persona de Mediana Edad , Marruecos/epidemiología , Mycobacterium tuberculosis/citología , Fenotipo , Tuberculosis Pleural/epidemiología , Tuberculosis Pleural/genética , Factor de Necrosis Tumoral alfa/biosíntesis , Uganda/epidemiología , Adulto Joven
4.
J Virol ; 84(20): 10522-32, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20686035

RESUMEN

In order to better understand the broad applicability of adenovirus (Ad) as a vector for human vaccine studies, we compared four adenovirus (Ad) vectors from families C (Ad human serotype 5 [HAdV-5; here referred to as AdHu5]), D (HAdV-26; here referred to as AdHu26), and E (simian serotypes SAdV-23 and SAdV-24; here referred to as chimpanzee serotypes 6 and 7 [AdC6 and AdC7, respectively]) of the Adenoviridae. Seroprevalence rates and titers of neutralizing antibodies to the two human-origin Ads were found to be higher than those reported previously, especially in countries of sub-Saharan Africa. Conversely, prevalence rates and titers to AdC6 and AdC7 were markedly lower. Healthy human adults from the United States had readily detectable circulating T cells recognizing Ad viruses, the levels of which in some individuals were unexpectedly high in response to AdHu26. The magnitude of T-cell responses to AdHu5 correlated with those to AdHu26, suggesting T-cell recognition of conserved epitopes. In mice, all of the different Ad vectors induced CD8(+) T-cell responses that were comparable in their magnitudes and cytokine production profiles. Prime-boost regimens comparing different combinations of Ad vectors failed to indicate that the sequential use of Ad vectors from distinct families resulted in higher immune responses than the use of serologically distinct Ad vectors from the same family. Moreover, the transgene product-specific antibody responses induced by the AdHu26 and AdC vectors were markedly lower than those induced by the AdHu5 vector. AdHu26 vectors and, to a lesser extent, AdC vectors induced more potent Ad-neutralizing antibody responses. These results suggest that the potential of AdHu26 as a vaccine vector may suffer from limitations similar to those found for vectors based on other prevalent human Ads.


Asunto(s)
Adenoviridae/genética , Adenoviridae/inmunología , Vectores Genéticos , Vacunas Virales/genética , Adenoviridae/clasificación , Adenovirus Humanos/clasificación , Adenovirus Humanos/genética , Adenovirus Humanos/inmunología , Adenovirus de los Simios/clasificación , Adenovirus de los Simios/genética , Adenovirus de los Simios/inmunología , Adulto , África del Sur del Sahara , Animales , Anticuerpos Neutralizantes/sangre , Anticuerpos Antivirales/sangre , Linfocitos T CD8-positivos/inmunología , Células CHO , Cápside/inmunología , Línea Celular , Cricetinae , Cricetulus , Femenino , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Humanos , Ratones , Ratones Endogámicos BALB C , Virus de la Rabia/inmunología , Receptores Virales/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Estudios Seroepidemiológicos , Serotipificación , Especificidad de la Especie
5.
Clin Exp Immunol ; 130(3): 432-40, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12452833

RESUMEN

Naïve T-cells divide and mature, both functionally and phenotypically, upon stimulation through the T-cell receptor. Although much is known about the overall changes that occur in naïve cells upon TCR stimulation, and the different memory/effector populations that arise following stimulation, the relationship between cell division and functional and phenotypical changes that occur after activation is poorly understood. Here, we examine the early stages of human naïve and antigen-experienced T-cell activation, and the relationship between cell division and acquisition of effector function during the transition from resting antigen-experienced or naïve T-cells into effector cells. Stimulated naïve T-cells proliferate prior to acquisition of effector function, as measured by cytokine production and expression of effector-associated cell surface molecules. Additionally, we show that interlukin-7 (IL-7) can drive proliferation of naïve T-cells without TCR:MHC peptide interactions. IL-7 alone does not, however, drive the proliferation of antigen-experienced T-cells. Memory T-cells will divide in response to exogenous IL-7 but only in the presence of naïve T-cells and IL-2. This study contributes to the current understanding of the mechanistic differences between naïve and memory T-cell responses by defining the functional and phenotypic changes that occur to T-cells after stimulation.


Asunto(s)
Antígenos/inmunología , Activación de Linfocitos , Linfocitos T/inmunología , Antígenos/análisis , División Celular , Células Cultivadas , Citometría de Flujo , Humanos , Memoria Inmunológica , Interleucina-2/inmunología , Interleucina-7/inmunología , Interleucina-7/farmacología , Linfocitos T Reguladores/inmunología
6.
J Immunol ; 167(11): 6663-8, 2001 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-11714838

RESUMEN

The effects of HIV infection upon the thymus and peripheral T cell turnover have been implicated in the pathogenesis of AIDS. In this study, we investigated whether decreased thymic output, increased T cell proliferation, or both can occur in HIV infection. We measured peripheral blood levels of TCR rearrangement excision circles (TREC) and parameters of cell proliferation, including Ki67 expression and ex vivo bromodeoxyuridine incorporation in 22 individuals with early untreated HIV disease and in 15 HIV-infected individuals undergoing temporary interruption of therapy. We found an inverse association between increased T cell proliferation with rapid viral recrudescence and a decrease in TREC levels. However, during early HIV infection, we found that CD45RO-CD27high (naive) CD4+ T cell proliferation did not increase, despite a loss of TREC within naive CD4+ T cells. A possible explanation for this is that decreased thymic output occurs in HIV-infected humans. This suggests that the loss of TREC during HIV infection can arise from a combination of increased T cell proliferation and decreased thymic output, and that both mechanisms can contribute to the perturbations in T cell homeostasis that underlie the pathogenesis of AIDS.


Asunto(s)
Infecciones por VIH/inmunología , Infecciones por VIH/patología , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/patología , Timo/inmunología , Timo/patología , Adulto , Anciano , Anciano de 80 o más Años , Terapia Antirretroviral Altamente Activa , Bromodesoxiuridina/metabolismo , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/patología , Reordenamiento Génico de Linfocito T , Infecciones por VIH/tratamiento farmacológico , Humanos , Memoria Inmunológica , Interfase/inmunología , Antígeno Ki-67/biosíntesis , Activación de Linfocitos , Persona de Mediana Edad , Subgrupos de Linfocitos T/metabolismo , Timo/metabolismo
7.
J Virol ; 75(24): 11983-91, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11711588

RESUMEN

Human immunodeficiency virus (HIV)-specific T-cell responses are thought to play a key role in viral load decline during primary infection and in determining the subsequent viral load set point. The requirements for this effect are unknown, partly because comprehensive analysis of total HIV-specific CD4(+) and CD8(+) T-cell responses to all HIV-encoded epitopes has not been accomplished. To assess these responses, we used cytokine flow cytometry and overlapping peptide pools encompassing all products of the HIV-1 genome to study total HIV-specific T-cell responses in 23 highly active antiretroviral therapy naïve HIV-infected patients. HIV-specific CD8(+) T-cell responses were detectable in all patients, ranging between 1.6 and 18.4% of total CD8(+) T cells. HIV-specific CD4(+) T-cell responses were present in 21 of 23 patients, although the responses were lower (0.2 to 2.94%). Contrary to previous reports, a positive correlation was identified between the plasma viral load and the total HIV-, Env-, and Nef-specific CD8(+) T-cell frequency. No correlation was found either between viral load and total or Gag-specific CD4(+) T-cell response or between the frequency of HIV-specific CD4(+) and CD8(+) T cells. These results suggest that overall frequencies of HIV-specific T cells are not the sole determinant of immune-mediated protection in HIV-infection.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Infecciones por VIH/inmunología , VIH/inmunología , Carga Viral , Animales , Citometría de Flujo , Productos del Gen env/inmunología , Productos del Gen gag/inmunología , Productos del Gen nef/inmunología , Infecciones por VIH/virología , Humanos , Ratones , Productos del Gen nef del Virus de la Inmunodeficiencia Humana
8.
Immunol Lett ; 79(1-2): 117-25, 2001 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-11595298

RESUMEN

Human immunodeficiency virus (HIV)-specific CD8+ T cells play an important role in controlling HIV infection. Accurate monitoring of these cells is crucial in determining the effects of HIV therapy and vaccine efficacy. Using an intracellular cytokine staining based assay, we are able to directly quantify functional HIV-specific CD8+ T cells. This assay is highly reproducible, and can be performed using both fresh and cryopreserved peripheral blood cells. Importantly, this assay can be used to examine multiple HIV-peptide epitopes simultaneously, and is independent of patient HLA haplotype. Here, we examine the HIV-specific CD8+ T cell response to 95 optimized HIV-derived cytotoxic T lymphocyte (CTL) epitopes in 21 HIV-infected patients of varying HLA haplotype, using peptide mixes and matrices. We find that when using mixes of multiple HIV peptides, the CD8+ T cell response to the mixture is equivalent to the sum of the responses to the individual peptides contained therein. Detailed comparison of the responses in patients suggests that most patients generate a diverse CD8+ T cell response, recognizing multiple HIV epitopes derived from HIV Gag, Pol, Env, or Nef. Although some patients sharing HLA alleles occasionally recognize common peptides, rarely are responses to those peptides dominant within the same group of patients. These results confirm our previous findings that the responses to single HIV-peptides are rarely representative of the entire HIV response.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Citocinas/biosíntesis , Infecciones por VIH/inmunología , VIH-1/inmunología , Secuencia de Aminoácidos , Epítopos/administración & dosificación , Epítopos/genética , Antígenos VIH/administración & dosificación , Antígenos VIH/genética , Antígenos HLA , Haplotipos , Humanos , Técnicas In Vitro , Líquido Intracelular/inmunología , Linfocitos T Citotóxicos/inmunología
9.
J Acquir Immune Defic Syndr ; 26(5): 423-34, 2001 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-11391161

RESUMEN

Mycophenolic acid (MPA) increases the activity of both abacavir (ABC) and didanosine (ddI) in vitro against wild-type and multinucleoside-resistant HIV. We treated 7 patients with diagnosed AIDS who did not respond to eight or more antiretroviral therapies in an open label pilot study with mycophenolate mofetil (MMF), ABC, ddI, amprenavir (APV), and ritonavir (RTV), with or without efavirenz (EFV). Therapy was well tolerated despite the patients' advanced disease states. No significant decline in lymphocyte or other blood counts was observed. Median HIV RNA was 5.26 log10 copies/ml at entry, 4.53 log10 copies/ml at 4 weeks, and 5.13 log10 copies/ml at 16 weeks. Median CD4+ count was 34 cells/microl at entry and 39 cells/microl at 16 weeks of therapy. CD4+ counts increased further in five study subjects on extended therapy to 25 weeks (median 27 cells/microl at entry, 66 cells/microl at close), despite loss of virologic suppression in 4 of 5 cases. MPA can induce apoptosis in lymphocytes in vitro. However despite viral rebound, cell surface markers of apoptosis and activation declined in total CD3+ cells and CD3+/CD4+ cells twofold to fourfold in 4 of 5 adherent study subjects at 16 weeks, reaching levels comparable with those found in seronegative donors. Although low-dose MMF appears safe in late-stage HIV disease, this study did not demonstrate virologic efficacy. Higher doses of MMF may be more effective. With careful monitoring of toxicities and pharmacokinetics, MMF deserves further testing in HIV therapy.


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Infecciones por VIH/tratamiento farmacológico , VIH-1/efectos de los fármacos , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapéutico , Inhibidores de la Transcriptasa Inversa/uso terapéutico , Adulto , Fármacos Anti-VIH/farmacología , Recuento de Linfocito CD4 , Farmacorresistencia Microbiana/genética , Resistencia a Múltiples Medicamentos/genética , Quimioterapia Combinada , Citometría de Flujo , Infecciones por VIH/virología , VIH-1/inmunología , Humanos , Ácido Micofenólico/farmacocinética , Proyectos Piloto , ARN Viral/sangre , Inhibidores de la Transcriptasa Inversa/farmacología , Terapia Recuperativa , Resultado del Tratamiento
10.
J Virol ; 75(14): 6508-16, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11413318

RESUMEN

We measured the longitudinal responses to 95 HLA class I-restricted human immunodeficiency virus (HIV) epitopes and an immunodominant HLA A2-restricted cytomegalovirus (CMV) epitope in eight treatment-naive HIV-infected individuals, using intracellular cytokine staining. Patients were treated with highly active antiretroviral therapy (HAART) for a median of 78 weeks (range, 34 to 121 weeks). Seven of eight patients maintained an undetectable viral load for the duration of therapy. A rapid decline in HIV-specific CD8(+) T-cell response was observed at initiation of therapy. After an undetectable viral load was achieved, a slower decrease in HIV-specific CD8(+) T-cell response was observed that was well described by first-order kinetics. The median half-life for the rate of decay was 38.8 (20.3 to 68.0) weeks when data were expressed as percentage of peripheral CD8(+) T cells. In most cases, data were similar when expressed as the number of responding CD8(+) T cells per microliter of blood. In subjects who responded to more than one HIV epitope, rates of decline in response to the different epitopes were similar and varied by a factor of 2.2 or less. Discontinuation of treatment resulted in a rapid increase in HIV-specific CD8(+) T cells. Responses to CMV increased 1.6- and 2.8-fold within 16 weeks of initiation of HAART in two of three patients with a measurable CMV response. These data suggest that HAART quickly starts to restore CD8(+) T-cell responses to other chronic viral infections and leads to a slow decrease in HIV-specific CD8(+) T-cell response in HIV-infected patients. The slow decrease in the rate of CD8(+) T-cell response and rapid increase in response to recurrent viral replication suggest that the decrease in CD8(+) T-cell response observed represents a normal memory response to withdrawal of antigen.


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Linfocitos T CD8-positivos/inmunología , Infecciones por VIH/inmunología , Adulto , Terapia Antirretroviral Altamente Activa , Linfocitos T CD8-positivos/virología , Enfermedad Crónica , Citomegalovirus/inmunología , Epítopos de Linfocito T/inmunología , Antígenos VIH/inmunología , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/virología , Antígeno HLA-A2/inmunología , Humanos , Recuento de Linfocitos , Persona de Mediana Edad , Carga Viral
11.
Blood ; 97(5): 1458-66, 2001 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-11222394

RESUMEN

Hematopoietic stem cell transplantation (HSCT) is followed by profound immunodeficiency. Thymic function is necessary for de novo generation of T cells after HSCT. Circulating CD45RA(+) naive T-cell levels are predictive of antigen-specific T-cell responses in the absence of graft-versus-host disease (GVHD). These T cells may not represent recent thymic emigrants, since naive T cells may maintain this phenotype if not antigen-activated. To accurately measure thymic output after HSCT and determine the factors that influence thymic function, T-cell receptor excision circles (TRECs) were examined in CD4(+) and CD8(+) cells from a cross-section of patients following HSCT. TREC levels rose weeks after HSCT and could be detected in patients 6 years after HSCT. TREC levels correlated with the frequency of phenotypically naive T cells, indicating that such cells were not expanded progeny of naive T cells present in the donor graft. Chronic GVHD was the most important factor that predicted low TREC levels even years after HSCT. Patients with a history of resolved GVHD had decreased numbers of TREC, compared with those with no GVHD. Because few adults had no history of GVHD, it was not possible to determine whether age alone inversely correlated with TREC levels. Recipients of cord blood grafts had no evidence of decreased TREC induced by immunosuppressive prophylaxis drugs. Compared with unrelated donor grafts, recipients of matched sibling grafts had higher TREC levels. Collectively, these data suggest that thymopoiesis is inhibited by GVHD. Larger studies will be needed to determine the independent contributions of age and preparative regimen to post-transplant thymopoietic capacity.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/efectos adversos , Timo/inmunología , Adolescente , Adulto , Factores de Edad , Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/metabolismo , Niño , Preescolar , Estudios de Cohortes , Estudios Transversales , Reparación del ADN , Sangre Fetal , Enfermedad Injerto contra Huésped/complicaciones , Enfermedad Injerto contra Huésped/tratamiento farmacológico , Enfermedad Injerto contra Huésped/inmunología , Humanos , Inmunosupresores/administración & dosificación , Inmunosupresores/farmacología , Lactante , Antígenos Comunes de Leucocito/sangre , Estudios Longitudinales , Persona de Mediana Edad , Estudios Prospectivos , Estadísticas no Paramétricas , Timo/patología , Trasplante Homólogo/efectos adversos
12.
J Exp Med ; 192(12): 1819-32, 2000 Dec 18.
Artículo en Inglés | MEDLINE | ID: mdl-11120778

RESUMEN

The highly sensitive quantitation of virus-specific CD8(+) T cells using major histocompatibility complex-peptide tetramer assays has revealed higher levels of cytotoxic T lymphocytes (CTLs) in acute and chronic virus infections than were recognized previously. However, studies in lymphocytic choriomeningitis virus infection have shown that tetramer assays may include measurement of a substantial number of tetramer-binding cells that are functionally inert. Such phenotypically silent CTLs, which lack cytolytic function and do not produce interferon (IFN)-gamma, have been hypothesized to explain the persistence of virus in the face of a quantitatively large immune response, particularly when CD4 help is impaired. In this study, we examined the role of functionally inert CTLs in chronic HIV infection. Subjects studied included children and adults (n = 42) whose viral loads ranged from <50 to >100,000 RNA copies/ml plasma. Tetramer assays were compared with three functional assays: enzyme-linked immunospot (Elispot), intracellular cytokine staining, and precursor frequency (limiting dilution assay [LDA]) cytotoxicity assays. Strong positive associations were observed between cell numbers derived by the Elispot and the tetramer assay (r = 0.90). An even stronger association between tetramer-derived numbers and intracellular cytokine staining for IFN-gamma was present (r = 0.97). The majority (median 76%) of tetramer-binding cells were consistently detectable via intracellular IFN-gamma cytokine staining. Furthermore, modifications to the LDA, using a low input cell number into each well, enabled LDAs to reach equivalence with the other methods of CTL enumeration. These data together show that functionally inert CTLs do not play a significant role in chronic pediatric or adult HIV infection.


Asunto(s)
Citotoxicidad Inmunológica , Infecciones por VIH/inmunología , Linfocitos T Citotóxicos/inmunología , Adulto , Recuento de Linfocito CD4 , Niño , Enfermedad Crónica , Pruebas Inmunológicas de Citotoxicidad , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Infecciones por VIH/tratamiento farmacológico , VIH-1/genética , VIH-1/inmunología , VIH-1/fisiología , Humanos , Interferón gamma/análisis , Recuento de Linfocitos , Fragmentos de Péptidos/inmunología , ARN Viral/análisis , Linfocitos T Citotóxicos/citología , Carga Viral
13.
J Virol ; 74(19): 9144-51, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10982361

RESUMEN

Recent studies of human immunodeficiency virus (HIV)-specific CD8(+) T cells have focused on responses to single, usually HLA-A2-restricted epitopes as surrogate measures of the overall response to HIV. However, the assumption that a response to one epitope is representative of the total response is unconfirmed. Here we assess epitope immunodominance and HIV-specific CD8(+) T-cell response complexity using cytokine flow cytometry to examine CD8(+) T-cell responses in 11 HLA-A2(+) HIV(+) individuals. Initial studies demonstrated that only 4 of 11 patients recognized the putative immunodominant HLA-A2-restricted p17 epitope SLYNTVATL, suggesting that the remaining subjects might lack significant HIV-specific CD8(+) T-cell responses. However, five of six SLYNTVATL nonresponders recognized other HIV epitopes, and two of four SLYNTVATL responders had greater responses to HIV peptides restricted by other class I alleles. In several individuals, no HLA-A2-restricted epitopes were recognized, but CD8(+) T-cell responses were detected to epitopes restricted by other HLA class I alleles. These data indicate that an individual's overall CD8(+) T-cell response to HIV is not adequately represented by the response to a single epitope and that individual major histocompatibility complex class I alleles do not predict an immunodominant response restricted by that allele. Accurate quantification of total HIV-specific CD8(+) T-cell responses will require assessment of the response to all possible epitopes.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Infecciones por VIH/inmunología , VIH-1/inmunología , Antígenos de Histocompatibilidad Clase I/inmunología , Presentación de Antígeno , Citotoxicidad Inmunológica , Haplotipos , Antígenos de Histocompatibilidad Clase I/genética , Humanos
14.
Lancet ; 355(9218): 1875-81, 2000 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-10866444

RESUMEN

BACKGROUND: The potential benefits of haematopoietic stem-cell transplantation are tempered by the depletion of T-cells accompanying this procedure. We used a new technique which quantifies the excisional DNA products of T-cell-receptor (TCR) gene rearrangement to measure thymic output directly in patients with multiple myeloma, and thus assessed the contribution of the thymus to immune recovery after transplantation. METHODS: We studied 40 patients, 34-66 years of age, who had been randomly assigned myeloablative chemotherapy and autologous peripheral-blood haematopoietic stem-cell transplantation with unmanipulated grafts or grafts enriched for CD34 stem cells. CD4 and CD8 T-cell counts were measured, thymic output was estimated serially until 2 years after transplantation, and percentages of naive T-cells were measured. FINDINGS: The production of substantial numbers of new naive T cells by the thymus could be detected by 100 days post-transplant; there was a significant inverse relation between age and recovery of new T cells. In the CD34-unselected group, numbers of TCR-rearrangement excision circles returned to baseline after 2 years, whereas in the CD34-selected group, numbers at 2 years were significantly higher than both baseline numbers (p=0.004), and 2-year numbers in the unselected group (p=0.046). Increased thymic output correlated with, and was predictive of, increased naive T-cell numbers and broader T-cell-receptor repertoires. INTERPRETATION: Our results provide evidence that the adult thymus contributes more substantially to immune reconstitution after haematopoietic stem-cell transplantation than was previously thought, and therefore could be a target for therapeutic intervention.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Mieloma Múltiple/terapia , Receptores de Antígenos de Linfocitos T/inmunología , Linfocitos T , Timo/inmunología , Adulto , Anciano , Antígenos CD/inmunología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Reordenamiento Génico de Linfocito T , Factor Estimulante de Colonias de Granulocitos/administración & dosificación , Humanos , Recuento de Linfocitos , Persona de Mediana Edad , Mieloma Múltiple/tratamiento farmacológico , Mieloma Múltiple/inmunología , Agonistas Mieloablativos/administración & dosificación , Acondicionamiento Pretrasplante
15.
J Virol ; 74(1): 371-8, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10590126

RESUMEN

Vaccine vectors derived from Venezuelan equine encephalitis virus (VEE) that expressed simian immunodeficiency virus (SIV) immunogens were tested in rhesus macaques as part of the effort to design a safe and effective vaccine for human immunodeficiency virus. Immunization with VEE replicon particles induced both humoral and cellular immune responses. Four of four vaccinated animals were protected against disease for at least 16 months following intravenous challenge with a pathogenic SIV swarm, while two of four controls required euthanasia at 10 and 11 weeks. Vaccination reduced the mean peak viral load 100-fold. The plasma viral load was reduced to below the limit of detection (1,500 genome copies/ml) in one vaccinated animal between 6 and 16 weeks postchallenge and in another from week 6 through the last sampling time (40 weeks postchallenge). The extent of reduction in challenge virus replication was directly correlated with the strength of the immune response induced by the vectors, which suggests that vaccination was effective.


Asunto(s)
Virus de la Encefalitis Equina Venezolana/genética , Replicón/genética , Virus de la Inmunodeficiencia de los Simios/inmunología , Vacunas Sintéticas/administración & dosificación , Animales , Anticuerpos Antivirales/biosíntesis , Citotoxicidad Inmunológica , Genes Virales , Vectores Genéticos , Macaca mulatta , Virus de la Inmunodeficiencia de los Simios/genética , Virus de la Inmunodeficiencia de los Simios/patogenicidad , Vacunas Sintéticas/genética
16.
AIDS Res Hum Retroviruses ; 15(13): 1219-28, 1999 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-10480635

RESUMEN

HIV-1-specific cytotoxic T cell (CTL) activity has been suggested to correlate with protection from progression to AIDS. We have examined the relationship between HIV-specific CTL activity and maintenance of peripheral blood CD4+ T lymphocyte counts and control of viral load in 17 long-term survivors (LTSs) of HIV-1 infection. Longitudinal analysis indicated that the LTS cohort demonstrated a decreased rate of CD4+ T cell loss (18 cells/mm3/year) compared with typical normal progressors (approximately 60 cells/mm3/year). The majority of the LTSs had detectable, variable, and in some individuals, quite high (>10(4) RNA copies/ml) plasma viral load during the study period. In a cross-sectional analysis, HIV-specific CTL activity to HIV Gag, Pol, and Env proteins was detectable in all 17 LTSs. Simultaneous analysis of HIV-1 Gag-Pol, and Env-specific CTLs and virus load in protease inhibitor-naive individuals showed a significant inverse correlation between Pol-specific CTL activity and plasma HIV-1 RNA levels (p = 0.001). Furthermore, using a mixed linear effects model the combined effects of HIV-1 Pol- and Env-specific CTL activity on the viral load were significantly stronger than the effects of HIV-1 Pol-specific CTL activity alone on predicted virus load. These data suggest that the presence of HIV-1-specific CTL activity in HIV-1-infected long-term survivors is an important component in the effective control of HIV-1 replication.


Asunto(s)
Infecciones por VIH/inmunología , Sobrevivientes de VIH a Largo Plazo , VIH-1/inmunología , Linfocitos T Citotóxicos/inmunología , Recuento de Linfocito CD4 , Linfocitos T CD4-Positivos/inmunología , Estudios Transversales , Pruebas Inmunológicas de Citotoxicidad , Productos del Gen pol/genética , Productos del Gen pol/metabolismo , Infecciones por VIH/virología , VIH-1/fisiología , Antígenos de Histocompatibilidad Clase I/clasificación , Antígenos de Histocompatibilidad Clase I/genética , Antígenos de Histocompatibilidad Clase I/inmunología , Humanos , Estudios Longitudinales , Masculino , Receptores CCR5/genética , Carga Viral
17.
Vaccine ; 17(23-24): 3124-35, 1999 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-10462249

RESUMEN

A live virus vaccine vector has been constructed from a molecularly cloned attenuated strain of Venezuelan equine encephalitis virus (VEE). High levels of foreign protein expression are regulated by an additional copy of the 26 S viral subgenomic RNA promoter. The position of this additional promoter and foreign gene in the VEE genome was predicted to have a major influence on expression level of the heterologous protein. Two sites in the genome were tested to determine the optimal site for expression of the matrix/capsid (MA/CA) coding region of human immunodeficiency virus (HIV-1). One vector contained the additional promoter and the MA/CA genes immediately downstream of the VEE E1 gene at the 3' end of the genome. In the second vector, the additional promoter was introduced immediately upstream from the authentic 26 S subgenomic promoter. Significantly higher levels of MA/CA were expressed from the downstream vector compared to the upstream vector. However, the stability of expression for both vectors was similar following passage in baby hamster kidney cells (BHK) cells. In BALB/c mice, the two vectors elicited similar levels of cellular immune responses to MA/CA as determined by bulk cytotoxic T-lymphocyte assays and precursor frequency analysis, but the humoral response induced by the downstream vector was significantly stronger. At 11 months post boosting with the downstream vector, serum antibody levels against HIV MA/CA were undiminished, and MA/CA specific CTLp were detectable in all mice tested. These findings suggest that VEE vectors can be optimized to elicit strong, balanced and long-lived immune responses to foreign viral proteins.


Asunto(s)
Vacunas contra el SIDA/genética , Virus de la Encefalitis Equina Venezolana/genética , Virus de la Encefalitis Equina Venezolana/inmunología , Vectores Genéticos/síntesis química , Vectores Genéticos/inmunología , VIH-1/genética , Vacunas de ADN/genética , Vacunas contra el SIDA/inmunología , Animales , Cápside/biosíntesis , Cápside/genética , Cápside/inmunología , Células Cultivadas , Cricetinae , Femenino , Genoma Viral , Anticuerpos Anti-VIH/biosíntesis , Anticuerpos Anti-VIH/sangre , VIH-1/inmunología , Humanos , Activación de Linfocitos/inmunología , Ratones , Ratones Endogámicos BALB C , Regiones Promotoras Genéticas/inmunología , Células Madre/inmunología , Linfocitos T Citotóxicos/inmunología , Proteínas de la Matriz Viral/biosíntesis , Proteínas de la Matriz Viral/genética , Proteínas de la Matriz Viral/inmunología
18.
J Virol ; 71(11): 8908-11, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9343257

RESUMEN

We have examined cross-clade HIV-specific cytotoxic T-lymphocyte (CTL) activity in peripheral blood of eight Zambian individuals infected with non-B-clade human immunodeficiency virus type 1 (HIV-1). Heteroduplex mobility assay and partial sequence analysis of env and gag genes strongly suggests that all the HIV-infected subjects were infected with clade C HIV-1. Six of eight C-clade HIV-infected individuals elicited CTL activity specific for recombinant vaccinia virus-infected autologous targets expressing HIV gag-pol-env derived from B-clade HIV-1 (IIIB). Recognition of individual recombinant HIV-1 B-clade vaccinia virus-infected targets expressing gag, pol, or env was variable among the patients tested, indicating that cross-clade CTL activity is not limited to a single HIV protein. These data demonstrate that HIV clade C-infected individuals can mount vigorous HIV clade B-reactive CTL responses.


Asunto(s)
Antígenos VIH/inmunología , Infecciones por VIH/inmunología , VIH-1/inmunología , Linfocitos T Citotóxicos/inmunología , Reacciones Cruzadas , ADN Viral/genética , Infecciones por VIH/virología , Humanos , Inmunidad Celular , Filogenia , Estados Unidos , Zambia
19.
J Virol ; 71(4): 3031-8, 1997 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9060663

RESUMEN

A molecularly cloned attenuated strain of Venezuelan equine encephalitis virus (VEE) has been genetically configured as a replication-competent vaccine vector for the expression of heterologous viral proteins (N. L. Davis, K. W. Brown, and R. E. Johnston, J. Virol. 70:3781-3787, 1996). The matrix/capsid (MA/CA) coding domain of human immunodeficiency virus type 1 (HIV-1) was cloned into the VEE vector to determine the ability of a VEE vector to stimulate an anti-HIV immune response in mice. The VEE-MA/CA vector replicated rapidly in the cytoplasm of baby hamster kidney (BHK) cells and expressed large quantities of antigenically identifiable MA/CA protein. When injected subcutaneously into BALB/c mice, the vector invaded and replicated in the draining lymphoid tissues, expressing HIV-1 MA/CA at a site of potent immune activity. Anti-MA/CA immunoglobulin G (IgG) and IgA antibodies were present in serum of all immunized mice, and titers increased after a second booster inoculation. IgA antibodies specific for MA/CA were detected in vaginal washes of mice that received two subcutaneous immunizations. Cytotoxic T-lymphocyte responses specific for MA/CA were detected following immunization with the MA/CA-expressing VEE vector. These findings demonstrate the ability of a VEE-based vaccine vector system to stimulate a comprehensive humoral and cellular immune response. The multifaceted nature of this response makes VEE an attractive vaccine for immunization against virus infections such as HIV-1, for which the correlates of protective immunity remain unclear, but may include multiple components of the immune system.


Asunto(s)
Vacunas contra el SIDA/inmunología , Virus de la Encefalitis Equina Venezolana/genética , Vectores Genéticos , Anticuerpos Anti-VIH/sangre , VIH-1/inmunología , Linfocitos T Citotóxicos/inmunología , Vagina/inmunología , Animales , Formación de Anticuerpos , Cápside/genética , Cápside/inmunología , Línea Celular , Cricetinae , Pruebas Inmunológicas de Citotoxicidad , Virus de la Encefalitis Equina Venezolana/inmunología , Femenino , Productos del Gen gag/genética , Productos del Gen gag/inmunología , Vectores Genéticos/inmunología , Humanos , Inmunidad Celular , Inmunidad Mucosa , Tejido Linfoide/inmunología , Ratones , Ratones Endogámicos BALB C , Vacunación , Vacunas Sintéticas/inmunología , Vagina/patología , Proteínas de la Matriz Viral/genética , Proteínas de la Matriz Viral/inmunología
20.
Am Ind Hyg Assoc J ; 45(9): 642-54, 1984 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6391130

RESUMEN

The resistance of 11 different protective garment materials to permeation by epichlorohydrin, perchloroethylene, trichloroethylene, and 1,2-dibromoethane were determined. Water was the collection medium in the epichlorohydrin tests with samples taken periodically and analyzed by gas chromatography. Because of the relatively low solubilities of the other three challenge liquids in water, air was used as the collection medium. The concentrations of the permeant vapors in an airstream which passed across the downstream sides of the membranes were determined automatically every 2 min with a flame ionization detector. Butyl rubber offers good protection against epichlorohydrin, with breakthrough occurring after 8 hrs. With the halogenated hydrocarbons, Viton and Vitrile provide protection for at least 12 and 24 hrs, respectively, while PVA showed no breakthrough in 24 hrs with trichloroethylene and dibromoethane. With perchloroethylene, nitrile breakthrough occurred in 5 hrs. The weight and volume changes which occurred when the materials were soaked in each of the challenge liquids were also determined. The log of these changes correlated moderately well with the log of the breakthrough time normalized by the square of the material thickness.


Asunto(s)
Ropa de Protección/normas , Solventes , Epiclorhidrina , Dibromuro de Etileno , Permeabilidad , Tetracloroetileno , Tricloroetileno
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...